A recent analysis of the National Cancer Database (NCDB) included 2995 women 70 and older treated between 2010–2014 following breast conserving surgery for early-stage hormone-receptor-positive, HER2-negative breast cancers treated with adjuvant ET or RT [51]. This evidence concerns the gene NR4A1 and breast carcinoma.